Month: April 2025

SHANGHAI, China, April 01, 2025 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission (the “SEC”) on April 1, 2025. The annual report, which contains the Company’s audited consolidate statements, can be accessed on the SEC’s website at https://www.sec.gov and on Hesai’s investor relations website at https://investor.hesaitech.com. The Company will also provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and holders of American depositary shares upon request. About Hesai Hesai Group is a global leader...

Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-YearAdjusted EBITDA Loss Improved by 32.4% Versus Prior YearSignificant Balance Sheet Transformation Underway in 2025 PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (OTC: SNAX) (“Stryve” or the “Company”), a leader in high-protein, better-for-you snacking, today unaudited preliminary Q4 2024 financial information and disclosed it had filed form 12b-25 for their Form 10K for the fiscal year ended December 31, 2024. FY 2024 Unaudited Preliminary financial information The unaudited preliminary financial information as of and for the year ended December 31, 2024, is as follows. The Company expects net sales of $21.0 million an increase of 18.5% versus the prior year, incur an operating loss of approximately $10.6 million an improvement of 31.2% versus the...

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces it has filed for an extension to submit its annual report for the year ended December 31, 2024 to the OTC The company is currently undergoing a mandatory Securities Exchange Commission (SEC) review process related to its Form 10 registration statement, which may impact the financial statements or disclosures in the annual report. Management anticipates filing the annual report by April 15, which is the expiration of the extension period. Jason Matuszewski, Chief Executive Officer of BioStem, stated:“We appreciate our shareholders’ patience as we navigate the final...

Continued improvement of the Company’s financial position through additional reduction of outstanding debt by Madryn Asset Management TORONTO, April 01, 2025 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company exchanged $11.0 million of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP (“Madryn”) for 379,311 shares of its Series Y preferred stock. Following the transaction, the Company had total debt obligations of approximately $35.5 million, down 54% from $76.7 million outstanding as of March 31, 2024, and down 11% from $39.7 million outstanding as of December 31, 2024. “Yesterday’s transaction builds upon our on-going efforts to optimize the capital structure...